IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography-Forecast (2016-2021)
[Report Updated: 26-02-2016]


Related Topics: Leukemia

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for IVIG
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

Immunoglobulin refers to the breakdown of blood plasma that contains antibody and Intravenous immunoglobulin (IVIG) can be defined as a blood product administered intravenously. This therapy applicable for individuals who cannot produce adequate amount of antibodies. Intravenous immunoglobulin therapy helps patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia.

This report identifies the intravenous immunoglobulin market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to intravenous immunoglobulin market.

Globally North America dominated the market for intravenous immunoglobulin in 2015 with highest market share due to higher awareness about intravenous immunoglobulin coupled with developed medical and healthcare establishment in the region. North America was followed by Europe and Asia-Pacific as the second and third largest regional market respectively, for intravenous immunoglobulin. However, Asia-Pacific is expected to be fastest growing regional segment during the period of study due to fast growing healthcare setup in the region especially in India and China along with growing intravenous immunoglobulin therapy in this region.

This report on global intravenous immunoglobulin covers different applications of intravenous immunoglobulin therapy, and also classifies the global intravenous immunoglobulin market based on the basis of route of administration and clinical trial phase and market size in various geographical regions.

On the basis of delivery method of the intravenous immunoglobulin, this report is segmented into two major segments as follows: Intravenous, Subcutaneous

This reports is also classified on the basis of applications of intravenous immunoglobulin therapy, based on this global intravenous immunoglobulin therapy market is classified into ten major segments as follows: Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome and others

This report also covers intravenous immunoglobulin therapy market on the basis of clinical trial outlooks, major segments covered in this report are as follows: IgG, IgA, IgM, IgE and IgD

This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for intravenous immunoglobulin in each of the region.

This report identifies all the major companies operating in the global intravenous immunoglobulin market. Some of the major companies’ profiles in detail are as follows:

Baxter International Inc.

China Biologics Products, Inc.

Biotest AG

Octapharma AG

LFB Biotechnologies

Table of Contents
for IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]

  • 1. Intravenous Immunoglobulin – Market Overview

    2. Executive Summary

    3. Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.2.1. Product Benchmarking

    3.2.2. End User Profiling

    3.2.3. Top 5 Financials Analysis

    4. Intravenous Immunoglobulin – Market Forces

    4.1. Drivers

    4.1.1. Rising reported of immunodeficiency diseases

    4.1.2. Increasing penetration of immunoglobulin replacement therapy

    4.2. Restraints

    4.2.1. Cost of IVIG therapy

    4.3. Opportunities

    4.4. Challenges

    4.5. Porter’s Five Forces Analysis

    4.5.1. Bargaining Power of Suppliers

    4.5.2. Bargaining Power of Buyers

    4.5.3. Threat of New Entrants

    4.5.4. Threat of Substitutes

    4.5.5. Degree of Competition

    5. Intravenous Immunoglobulin – Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Intravenous Immunoglobulin Market, By Application

    6.1. Hypogammaglobulinemia

    6.2. CIDP

    6.3. Immunodeficiency diseases

    6.4. Congenital AIDS

    6.5. Chronic Lymphocytic Leukemia

    6.6. Myasthenia Gravis

    6.7. Multifocal Motor Neuropathy

    6.8. ITP

    6.9. Kawasaki Disease

    6.10. Guillain-Barre Syndrome

    6.11. Others

    7. Intravenous Immunoglobulin Market, By Route of Administration

    7.1. Intravenous

    7.2. Subcutaneous

    8. Intravenous Immunoglobulin Market, By Clinical Trial Phase

    8.1. IgG

    8.2. IgA

    8.3. IgM

    8.4. IgE

    8.5. IgD

    9. Intravenous Immunoglobulin Market, By Geography

    9.1. Europe

    9.1.1. Germany

    9.1.2. France

    9.1.3. Italy

    9.1.4. Spain

    9.1.5. Russia

    9.1.6. U.K.

    9.1.7. Rest of Europe

    9.2. Asia Pacific

    9.2.1. China

    9.2.2. India

    9.2.3. Japan

    9.2.4. South Korea

    9.2.5. Rest of Asia-Pacific

    9.3. North America

    9.3.1. U.S.

    9.3.2. Canada

    9.3.3. Mexico

    9.4. Rest of the World (RoW)

    9.4.1. Brazil

    9.4.2. Rest of RoW

    10. Intravenous Immunoglobulin – Market Entropy

    10.1. Expansion

    10.2. Technological Developments

    10.3. Merger & Acquisitions, and Joint Ventures

    10.4. Supply- Contract

    11. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)

    11.1. Baxter International Inc.

    11.2. China Biologics Products, Inc.

    11.3. Biotest AG

    11.4. Octapharma AG

    11.5. LFB Biotechnologies

    11.6. Grifols SA

    11.7. Kedrion Biopharma

    11.8. Changchun Bio

    11.9. CSL Behring

    11.10. Hualan Biological Engineering Inc.

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    12. Appendix

    12.1. Abbreviations

    12.2. Sources

    12.3. Research Methodology

    12.4. Expert Insights

List Of Tables
in IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]

No

Additional Details

Publisher

Publisher Information

Reference

80264 | HCR 0233

Report Format

PDF

 Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market Analysis 2011-2017 and Forecast 2018-2023
SnapshotIntravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified b...
22 Sep 2017 by 99Strategy USD $2,533 (normally
USD $2,980)
More Info
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market Research Report 2011-2023
SummaryIntravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified bl...
14 Sep 2017 by HeyReport USD $1,947 (normally
USD $2,291)
More Info
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Intravenous Immuno...
29 Jun 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component B
Blood is a major necessity for patients suffering from injuries and viral infections, which require ...
01 Jun 2017 by Allied Market Research USD $4,565 (normally
USD $5,371)
More Info
SAVE 15% today! Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barré Syndrome, Kawasaki Disease,
CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS FOR STAKEHOLDERS1.3. KEY MARKET SEGME...
24 May 2017 by Allied Market Research USD $2,423 (normally
USD $2,851)
More Info
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017 to 2021
The Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017-2021 is a valuable...
15 May 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Intravenous Immuno...
26 Apr 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017 to 2021
The Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017-2021 is a valuabl...
25 Apr 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Global Intravenous Immunoglobulin (IVIg) Market 2012- 2022
SummaryBased on products type, the report describes major products type share of regional market. Pr...
01 Apr 2017 by HeyReport USD $1,666 (normally
USD $1,960)
More Info
SAVE 15% today! Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)
Executive SummaryThe market is driven by the consumer awareness of health care resulting in access f...
01 Jan 2016 by Azoth Analytics USD $1,870 (normally
USD $2,200)
More Info

We Stock...